Articles related to PROSTATE CANCER

In a landmark study, researchers found that each doubling of PSA levels in men over 70 doubles the risk of prostate cancer death, highlighting the critical need for tailored screening approaches in older patients.

In a novel approach to combat metastatic castration-resistant prostate cancer, ODM-208, targeting cytochrome P450 11A1, has shown promising results in reducing prostate-specific antigens and testosterone levels, offering new hope in a challenging therapeutic area.

In a recent high-profile case, a jury awarded over $2 million in a robot-assisted prostate surgery lawsuit, underlining the critical importance of surgical precision and accountability in advanced medical procedures.

In a significant shift, a new phase 3 trial suggests reconsidering adjuvant radiotherapy after radical prostatectomy, as many patients may not require it long-term, potentially reducing morbidity risks.

Prostate cancer survival rates have improved, but the incidence is rising, particularly for advanced cases. Addressing disparities in care is crucial.

The management of low-risk prostate cancer has seen a significant shift over the last two decades, with active surveillance increasingly becoming the preferred approach. However, despite this progress, the overtreatment of low-risk disease remains a concern, underscoring the need for continued refinement in patient selection and monitoring strategies.